期刊
PEDIATRIC NEPHROLOGY
卷 26, 期 7, 页码 1001-1015出版社
SPRINGER
DOI: 10.1007/s00467-010-1692-x
关键词
Focal and segmental glomerulosclerosis; Podocyte; Molecular pathogenesis; Therapy
资金
- NIH [K08DK082495-01]
- Nephcure foundation
- Doris Duke Clinical Scientist Development Award
Focal and segmental glomerulosclerosis (FSGS) is an important cause of steroid-resistant nephrotic syndrome in adults and children. It is responsible for 5-20% of all cases of end-stage kidney disease (ESKD) in the United States. The pathogenesis of FSGS has not been fully elucidated; however, data from molecular studies of familial cases in the last two decades suggest that FSGS is a defect of the podocyte. The therapeutic agents available for treatment of FSGS are not very effective and only a small percentage of affected individuals will achieve complete remission. Recent data from molecular biology and molecular genetics has provided insight into the mechanisms of action of old agents and also identification of other novel therapeutic targets. This review focuses on recent advances in the molecular pathogenesis of FSGS and currently available therapeutic agents as well as potential novel therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据